Detection by PCR of Porphyromonas gingivalis and genotypes fimA II, IV e ragB+ in the subgingival biofilm, before and 180 days after conventional periodontal treatment and associated with antibiotic therapy in smoking patients with chronic periodontitis / Detecção por PCR de Porphyromonas gingivalis e dos genótipos fimA II, IV e ragB+ no biofilme subgengival, antes e 180 dias após o tratamento periodontal convencional e associado à terapia antimicrobiana em pacientes fumantes com periodontite crônica

AUTOR(ES)

Irineu Gregnanin Pedron

DATA DE PUBLICAÇÃO

2008

RESUMO

Periodontal diseases are local infections that present morbidity and have been relation with others systemic diseases or complications. Smoking patients present high levels and bigger predisposition to the severe and advanced periodontal diseases. The systemic administration of antibiotics, mainly metronidazole (M) and amoxicillin (A), associated to the mechanical periodontal treatment (scaling and root planing - SRP) has been largely researched referring to the chronic periodontal diseases. However, not much has been cleared up referring to the effects of those treatments about Porphyromonas gingivalis and its genotypes. The purpose of this research was to evaluate the clinical effects (depth probing - DP, clinical attachment level - CAL, plaque index - PI, gingival bleeding - GB, bleeding on probing - BOP, and supuration - SUP) and microbiological (referring to the presence of P. gingivalis and its genotypes fimA II, fimA IV and ragB) after 180 days of the mechanical periodontal treatment (SRP) associated to the systemic administration of antibiotic (SRP+M+A), compared to the mechanical periodontal treatment (SRP) in smoking patients with chronic periodontitis, by using the conventional PCR (specific primers to the 16S rRNA); to associate the P. gingivalis presence and its genotypes fimA II, fimA IV and ragB with depth probing (DP) of the researched population. 167 samples from the sites of 20 subjects treated with SRP (n=11) and SRP+M+A (n=9) have been evaluated, at the baseline and 180 days after the therapy. Clinical parameters (DP, CAL, PI, GB, BOP and SUP) and microbiological samples were evaluated in both moments. The detection of P. gingivalis frequence was made by using conventional PCR, and also to the genotypes fimA II, fimA IV and ragB. There was no statistically significative difference between the mechanical periodontal treatment associated to the systemic administration of antibiotics (SRP+M+A) and the mechanical periodontal treatment (SRP), in the smoking patients, related to the detection of the P. gingivalis. The SRP group showed more effective (statiscally significative) on the reduction of the genotype ragB prevalence, comparing to the SRP+M+A group, after 180 days of therapy. No statistically significative relation between the prevalence of P. gingivalis and its genotypes fimA II, fimA IV e ragB with DP at the baseline have been observed.

ASSUNTO(S)

porphyromonas gingivalis metronidazol metronidazole amoxicillin periodontite tabaco tobacco porphyromonas gingivalis therapy periodontitis amoxicilina terapia resultado de tratamento treatment outcome

Documentos Relacionados

• Avaliação do efeito do tratamento periodontal convencional e associado à terapia antimicrobiana em pacientes com periodontite crônica sobre os níveis de Porphyromonas gingivalis e dos genótipos fimA II e IV no biofilme subgengival.
• DetecÃÃo de porphyromonas gingivalis e dos genÃtipos fima ii e iv em portadores de periodontite agressiva
• Distribution of Porphyromonas gingivalis Strains with fimA Genotypes in Periodontitis Patients
• Frequency of Porphyromonas gingivalis fimA in smokers and nonsmokers after periodontal therapy
• Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats.